NCT05776056View on ClinicalTrials.gov

Methylphenidate for the Treatment of PTSD With Associated Neurocognitive Complaints

PHASE4RecruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

February 5, 2024

Primary Completion Date

July 6, 2026

Study Completion Date

March 31, 2027

Conditions
Posttraumatic Stress Disorder (PTSD)
Interventions
DRUG

Methylphenidate

Methylphenidate 10mg will be taken twice daily.

DRUG

Placebo

An inactive pill (placebo) will be taken twice daily.

Trial Locations (3)

35233-1927

RECRUITING

Birmingham VA Medical Center, Birmingham, AL, Birmingham

35404-5015

RECRUITING

Tuscaloosa VA Medical Center, Tuscaloosa, AL, Tuscaloosa

98108-1532

RECRUITING

VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle

All Listed Sponsors
lead

VA Office of Research and Development

FED